, /PRNewswire/ -- The global protein expression market size is estimated to grow by .40 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.
1% during the forecast period. Increasing advances in proteomics research is driving market growth, with a trend towards increasing importance of promotional activities. However, lack of skilled laboratory professionals poses a challenge.
Key market players include Agilent Technologies Inc., Amgen Inc., and Co.
, Bio Rad Laboratories Inc., Bioneer Corp., Danaher Corp.
, GenScript Biotech Corp., LGC Science Group Holdings Ltd., Lonza Group Ltd.
, Merck and Co. Inc., New England Biolabs Inc.
, Oxford Expression Technology Ltd., Pfizer Inc., Promega Corp.
, QIAGEN NV, Sartorius AG, Sino Biological Inc., Synbio Technologies, Takara Holdings Inc., and Thermo Fisher Scientific Inc.
. Get a detailed analysis on regions, market segments, customer landscape, and companies- The Protein Expression Market faces unique challenges due to niche applications and regulatory restrictions. Brand visibility plays a minimal role in sales.
Instead, vendors focus on expanding distribution networks and increasing product availability to end-users. Marketing and advertising are restricted, leading to low awareness. Thermo Fisher Scientific and Bio-Rad Laboratories use YouTube to educate customers about protein expression products.
Non-profit research organizations collaborate with pharmaceutical companies to promote aw.
